5043-01-6 Usage
General Description
6-FLUORO-2-NAPHTHOIC ACID is a chemical compound with the molecular formula C11H7FO2. It is a derivative of naphthalene, containing a fluorine atom and a carboxylic acid functional group. 6-FLUORO-2-NAPHTHOIC ACID is primarily used as an intermediate in the production of pharmaceuticals, agrochemicals, and dyes. Its chemical properties make it a valuable building block for the synthesis of various organic compounds. Additionally, 6-FLUORO-2-NAPHTHOIC ACID is used in research and development activities, particularly in the development of new drugs and materials. It is also known to have potential pharmaceutical applications due to its specific structural features.
Check Digit Verification of cas no
The CAS Registry Mumber 5043-01-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,4 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 5043-01:
(6*5)+(5*0)+(4*4)+(3*3)+(2*0)+(1*1)=56
56 % 10 = 6
So 5043-01-6 is a valid CAS Registry Number.
InChI:InChI=1/C11H7FO2/c12-10-4-3-7-5-9(11(13)14)2-1-8(7)6-10/h1-6H,(H,13,14)
5043-01-6Relevant articles and documents
SUBSTITUTED AMINO PHENYLACETIC ACIDS, DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE AS CYCLOOXYGENASE 2 (COX-2) INHIBITORS
-
Page 44-45, (2008/06/13)
Compounds of formula (I) wherein R is hydrogen, lower alkyl, (C3-C8)cycloalkyl, hydroxy, halo, lower alkoxy, trifluoromethoxy, trifluoromethyl or cyano; and A is biaryl, optionally substituted β-naphthyl, bicyclic heterocyclic aryl, (C3-C6)cycloalkylmonocyclic carbocyclic aryl, or (C5 or C6)cycloalkane fused-monocyclic carbocyclic aryl; pharmaceutically acceptable salts thereof, and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
Inhibitors of factor Xa
-
, (2008/06/13)
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
